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Abstract
Background: Curcumin, an Asian spice and food-coloring agent, is known for its anti-oxidant properties. We
propose that curcumin can improve diabetes-induced endothelial dysfunction through superoxide reduction.
Methods: Diabetes (DM) was induced in rats by streptozotocin (STZ). Daily curcumin oral feeding was started six
weeks after the STZ injection. Twelve weeks after STZ injection, mesenteric arteriolar responses were recorded in
real time using intravital fluorescence videomicroscopy. Superoxide and vascular protein kinase C (PKC-bII) were
examined by hydroethidine and immunofluorescence, respectively.
Results: The dilatory response to acetylcholine (ACh) significantly decreased in DM arterioles as compared to
control arterioles. There was no difference among groups when sodium nitroprusside (SNP) was used. ACh
responses were significantly improved by both low and high doses (30 and 300 mg/kg, respectively) of curcumin
supplementation. An oxygen radical-sensitive fluorescent probe, hydroethidine, was used to detect intracellular
superoxide anion (O2
●-) production. O2
●- production was markedly increased in DM arterioles, but it was
significantly reduced by supplementation of either low or high doses of curcumin. In addition, with a high dose of
curcumin, diabetes-induced vascular PKC-bII expression was diminished.
Conclusion: Therefore, it is suggested that curcumin supplementation could improve diabetes-induced endothelial
dysfunction significantly in relation to its potential to decrease superoxide production and PKC inhibition.
Background
Diabetes mellitus (DM) is characterized by chronic
hyperglycemia and its developed diabetic complications,
in particular, macroangiopathy and microangiopathy.
These pathophysiological complications are often
responsible for a decreased quality of life in diabetic
patients [1]. Experimental evidence indicates that hyper-
glycemia induces a series of cellular events that increase
the production of reactive oxygen species (ROS) [2]. In
the vessel, one of the most important ROS is superoxide
anion (O2●-), which is formed by the univalent reduc-
tion of oxygen [3]. There are multiple enzymes involved
in the production of O2●- and its derivatives in the vas-
culature, in particular, vascular protein kinase C (PKC)-
activated NAD(P)H oxidase [4]. The O2●- produced can
inactivate nitric oxide (NO) [5,6] directly, which leads to
decreased NO bioavailability [7,8]. NO is an important
molecule that involves many vascular functions. The
diabetes-induced increase in O2●- and its relation to
diabetic vascular complications have attracted a lot of
attention from several investigators. In animal models of
diabetes, antioxidant defense capacities were diminished
in certain tissues [9]. In addition, human and animal
studies have attempted to restore vascular endothelial
function using different types of antioxidants [10-12].
However, a critical evaluation of clinical trials suggests a
difference in the ROS specific to various vascular dis-
eases, thereby limiting the effectiveness of specific
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antioxidants [13]. Various herbal extracts are known to
possess antioxidant properties. Curcumin, a yellow pig-
ment from the root of Curcuma longa Linn., is a major
component of turmeric and commonly used as a spice
and food-coloring agent. Anti-oxidant and anti-inflam-
matory properties of curcumin have been well docu-
mented by previous studies [14-16]; however, the effect
of curcumin, especially on diabetes-induced vascular
O2
●- production, remains to be clarified. Recently, it has
been reported that curcumin (300 mg/kg) could
enhance the effect of vitamin C in protecting endothelial
cells, through an anti-oxidant effect [17]. Therefore, in
the present study, we tested the effects of curcumin sup-
plementation by using two different doses of 30 mg/kg
and 300 mg/kg on diabetes-induced endothelial dysfunc-
tion, which is associated with the direct effects on vas-
cular O2
●- production. We also examine the potential of
curcumin in inhibiting diabetes-induced PKC-activation
by using immunofluorescent staining.
Methods
Male Wistar rats were housed in a temperature- and
light-controlled environment, fed standard chow and
had acess to tap water ad libitum. The present study
was conducted in accordance with the guidelines for
animal experimentation established by the National
Research Council of Thailand and approved by the Insti-
tutional Animal Care and Use Committee of Chulalong-
korn University.
Induction of diabetes
The rats were randomly divided into non-diabetic and
diabetic groups. Diabetes was induced by a single intra-
venous injection of streptozotocin (55 mg/kg, STZ,
Sigma-Aldrich Co., USA). STZ was freshly prepared by
dissolving it in citrate buffer (pH 4.5, Sigma-Aldrich
Co., USA) and immediately injected into the tail vein
after 8 hours of fasting. Control rats received citrate buf-
fer of the same volume instead. STZ-induced diabetic
rats were included and retained for the experiments if
their blood glucose was greater than 200 mg/dL. Blood
glucose was measured by using a glucometer (ACCU-
CHEK, ADVANTAGE, Roche Diagnostics, Germany).
Animals were separated in five groups: (1) diabetes
(DM; n = 10), (2) DM-treated with curcumin (Cayman
Chemical Co., USA) 30 mg/kg (DM+cur30; n = 10),
(3) DM-treated with curcumin 300 mg/kg (DM+cur300;
n = 10), (4) control (con; n = 10), and (5) control trea-
ted with 300 mg/kg (con+cur300; n = 10). It is noted
that the daily oral feeding of curcumin was started at six
weeks after the STZ injection, since it has been shown
by our previous study that endothelial dysfunction in
STZ-rats has already occurred at six-weeks after STZ
injection [11].
Intravital observation of mesenteric arteriolar responses
Twelve weeks after STZ injection (or vehicle), the rats
were anesthetized with an intraperitoneal injection of
pentobarbital sodium (50 mg/kg). After tracheostomy,
polyethylene tubes were inserted into the external jugu-
lar vein and the common carotid artery for injection of
fluorescence tracers and monitoring of blood pressure,
respectively. The abdominal cavity was opened via mid-
line incision. The rat was placed on its right side on a
microscope stage. A small loop of intestine was exterior-
ized. The mesentery was carefully spread on a plexiglass
chamber with continuous perfusion by 1 mL/min
Krebs-Ringer buffer (37°C, pH 7.4, bubbled with 95% O2
and 5% CO2, composition in mmol/L: 135.7 NaCl, 4.7
KCl, 2.52 CaCl2, 1.18 KH2PO4, 1.64 MgSO4.7H2O, and
7.14 NaHCO3).
The second-order mesenteric arterioles (20 to 35 μm
in diameter) were viewed and recorded in real time by
an epi-illumination fluorescence videomicroscopy system
(Optiphot 2, Nikon, Japan) equipped with a 100 W mer-
cury lamp, CCD camera (Hamamatsu C2400, Japan), a
video recorder (VC-S5, Sharp, Japan) with a video timer
(VTG-33, For-A, Japan) and a 20× objective lens (CF
Plan Fluor, Nikon, Japan). Un-branched segments of
mesenteric arterioles were visualized by fluorescein iso-
thiocyanate-labeled dextran (FITC-Dextran 250,
5 μg/mL, Sigma-Aldrich Co., USA). The mesenteric
arterioles were allowed 15 minutes of stabilization and
pre-constricted with norepinephrine (10-5 mol/L, NE).
Topical applications of two vasodilators, acetylcholine
(10-5 mol/L, ACh) and NO donor sodium nitroprusside
(10-5 mol/L, SNP) were used to test the functions of the
endothelium and smooth muscle of mesenteric arter-
ioles, respectively. Changes in mesenteric arteriolar dia-
meters were analyzed off-line using digital image
software (Image-Pro Plus; Media Cybernetics, Inc., USA)
and expressed as the percentage of relaxation after pre-
constriction with NE by using the equation: [(DACh-
DNE)/DNE × 100].
Direct detection of superoxide content using ethidium
bromide fluorescence
Mesenteric arterioles were subjected to O2
●- measure-
ment based on fluorescence detection using the DNA-
binding fluorophore ethidium bromide (EB), which is
formed by O2
●- oxidation of hydroethidine (HE), using
490 nm excitation and 590 nm emission wavelengths
[18]. The mesentery preparation was perfused with a
buffer solution containing hydroethidine (5.0 × 10-6
mol/L, Polysciences, USA) saturated with a 95% N2 and
5% CO2 gas mixture for 60 minutes according to the
modified method described by Suzuki et al. [19,20]. The
number of nuclei labeled with ethidium bromide (EB-
positive nuclei) along the mesenteric arteriolar wall was
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determined at 60 minutes after the onset of hydroethi-
dine perfusion. The number of EB-stained nuclei was
counted per 100 microns of vessel length, as shown in
Figure 1. The selection of microvessels was limited to
arterioles with diameters ranging between 20 to 35 μm.
The results were confirmed by the other examiner, who
was blinded to grouping while counting.
Immunofluorescent staining for PKC-bII
Single unbranched small mesenteric arteries with dia-
meter ~100 μm were selected for study. The selected
microvessels were post-fixed in 4% paraformaldehyde
for 24 hours and were embedded in paraffin. These spe-
cimens were then deparaffinized in xylene, rehydrated in
graded ethanol and distilled water, antigen unmasked
with sodium citrate (10 mmol/L, pH 6.0, Dako, Den-
mark), and then exposed to a microwave heat source.
Incubation with anti-PKC-bII (1:100 dilution, Santa
Cruz Biotechnology, CA) was performed at room tem-
perature for 60 minutes. Sections were then washed in
PBS and incubated with the secondary antibody swine
anti-rabbit IgG-TRITC (1:50 dilution, Dako, Denmark)
for 30 minutes at room temperature. Labeling of the
arteries with secondary antibody alone was used as
negative control. Images were obtained using laser scan-
ning confocal microscopy (E800, Nikon, Japan) to estab-
lish the localization of PKC-bII in small mesenteric
arteries.
Measurement of plasma glucose and HbA1c
At the end of each experiment, a blood sample was col-
lected from each rat for further plasma glucose and gly-
cosylated hemoglobin (HbA1c) determination, using the
enzymatic and turbidimetric immunoinhibition methods,
respectively (Bangkok RIA Laboratory Co., Ltd., Bang-
kok, Thailand).
Statistical analysis
Data were expressed as means and standard errors of
means (SEM). For comparison among groups, one-way
analysis of variance (one-way ANOVA) and Tukey post-
hoc test were used. P < 0.01 and < 0.05 were considered
statistically significant. All data were analyzed using the
SPSS program (version 16.0) for Windows.
Results
Effects of curcumin on mean arterial blood pressure,
plasma glucose, and HbA1c levels
Twelve weeks after the injection of STZ, plasma glucose
and HbA1c values were significantly elevated in DM
rats as compared with control rats (Table 1). Supple-
mentation of curcumin for six weeks in control rats did
not alter the plasma glucose level. Interestingly, the
high-dose supplementation of curcumin in the DM
+cur300 group significantly lowered the levels of both
plasma glucose and HbA1c in comparison to the DM
group (P < 0.05). The low dose of curcumin supplemen-
tation (30 mg/kg) resulted in a slight decrease in plasma
glucose and significantly lower levels of HbA1c when
compared to values observed in the DM group (DM =
10.73 ± 0.32, DM+cur30 = 8.20 ± 0.88) (P < 0.05). How-
ever, treatment with a high dose of curcumin (300 mg/
kg) resulted in only a 32% decrease in plasma glucose
(DM = 459.0 ± 24.40, DM+cur300 = 310.00 ± 32.73),
and the values of plasma glucose and HbA1c of both
Figure 1 Ethidium bromide-positive nuclei. Number of ethidium
bromide (EB)-positive nuclei from the selected arteriolar wall. The
white lines depict the 100-micron vascular length where EB-positive
nuclei were counted. (Bar represents 50 μm).
Table 1 Mean arterial blood pressure (mABP; mmHg),







control 103.1 ± 3.57 101.8 ± 4.89 3.68 ± 0.17
con
+cur300
106.18 ± 3.93NS 106.8 ± 0.92NS 4.08 ± 0.41NS
DM 151.67 ± 9.68** 459.0 ± 24.40** 10.73 ± 0.32**




122.27 ± 8.68† 310.00 ± 32.73**, † 7.90 ± 0.97**,
†
Values are means ± SEM (n = 10) from the groups of: 12-week STZ (DM),
diabetes treated with curcumin (DM+cur30, DM+cur300), controls (con) and
controls treated with curcumin (con+cur300). NS, no significant difference
compared to control, **P < 0.01, significant difference compared to control
and control treated with curcumin; † P < 0.05, significant difference from
diabetic rats.
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DM+cur30 and DM+cur300 were significantly increased
when compared to the controls (P < 0.01). Therefore, it
is noted that the hyperglycemic state still existed in
both groups, DM+cur30 and DM+cur300.
In comparison with the control group, mean arterial
blood pressure (mABP) was significantly increased in
the DM group (P < 0.01). This increased mABP was sig-
nificantly attenuated with a high dose of curcumin sup-
plementation (P < 0.05).
Effects of curcumin on mesenteric arteriolar responses
The dilatory response of the mesenteric arterioles to
ACh (10-5 mol/L) was significantly decreased in the dia-
betic group (8.11 ± 0.44%) as compared to the control
group (12.82 ± 0.2%, P < 0.01) (figure 2). Both low and
high doses of curcumin supplementation (DM+cur30;
10.56 ± 0.2% and DM+cur300; 11.88 ± 0.52%) signifi-
cantly restored arteriolar dilation in response to ACh
(10-5 mol/L) in comparison to the physiology observed
in DM rats (8.11 ± 0.44%, P < 0.01). However, supple-
mentation with curcumin in the con+cur300 group did
not show any effects on ACh-induced arteriolar dilation
as compared to control (12.58 ± 1.07% and 12.82 ±
0.2%, respectively).
Figure 3 demonstrated that the impaired vasodilata-
tion in mesenteric arterioles of DM rats appeared to
involve only endothelial cell function but not smooth
muscle function because the vasodilation response to
SNP-activation was not altered in DM (12.55 ± 0.95%),
DM+cur30 (14.71 ± 0.38%), or DM+cur300 groups
(13.54 ± 1.40%).
Effect of curcumin on vascular superoxide production
By using hydroethidine-sensitive vascular superoxide,
the results showed that the number of EB-positive
nuclei per 100-micron vessel length were significantly
increased along the vascular walls of DM rats (19.6 ±
0.8) as compared to control rats (4.4 ± 0.6, P < 0.01).
The numbers of EB-positive nuclei observed in DM
+cur30 and DM+cur300 groups (10.8 ± 1.2 and 11.2 ±
1.8, respectively) were significantly reduced as compared
to DM (19.6 ± 1.8, P < 0.01) but remained higher than
levels observed in controls (4.4 ± 0.6, P < 0.05) (figure 4).
There was no significant difference between the EB-
positive nuclei in control and con+cur300 arterioles (4.4
± 0.6 and 5.2 ± 0.4 respectively).
Effect of curcumin on PKC-bII in mesenteric artery
Immunofluorescent staining of small mesenteric arteries
displayed a strong PKC-bII signal in DM rats (figure
5C). In contrast, the TRITC signals of anti-PKC-bII
antibodies were weak in control and DM+cur rat vessels
(figure 5B and 5D, respectively). Negative controls dis-
played minimal detectable fluorescence when the sec-
ondary antibodies were used alone (figure 5A).
Correlation between intracellular superoxide production
and arteriolar vasodilation
To examine the correlation between intracellular super-
oxide production and endothelial vascular response, fig-
ure 6 shows the relationship between superoxide
production and ACh-induced arteriolar vasodilation, for
every group. The results indicated that the EB-positive
nuclei along the mesenteric arterioles and the percent
changes in arteriolar diameters stimulated by ACh have
a significant correlation (0.78, P < 0.01). This correlation
is described by the linear equation:
Where x is the number of EB-positive nuclei per 100
um vessel length and y is the percentage change in
arteriolar diameter.
Discussion
In the present study, we have shown that the effect of
curcumin supplementation on diabetes-induced
Figure 2 Acetylcholine-induced arteriolar vasodilation. Acetylcholine-induced changes in mesenteric arteriolar diameters from control (con),
diabetes (DM) and curcumin-treated groups (DM+cur30, DM+cur300 and con+cur300). Data are means ± SEM (n = 5 for each group). NS, not
significant different compared to control arterioles; ** P < 0.01, significant difference compared to control arterioles; †† P < 0.01, significant
difference compared to diabetic arterioles.
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endothelial dysfunction is closely associated with its
potential as an anti-oxidant. The supplementation of
either low or high doses of curcumin appears to
improve diabetic endothelial dysfunction, as shown by
the increase in ACh-activated vasodilation. However,
there was no significant difference between low and
high doses in terms of restoring effects. In contrast to
this increase in ACh-vasorelaxation, endothelium-inde-
pendent relaxation in response to the NO donor SNP
was not affected by either diabetes or curcumin supple-
mentation. Therefore in this twelve-week model of dia-
betes, the NO-stimulated cGMP signaling in arteriolar
smooth muscle was not the primary target of treatment.
It is well established that hyperglycemia can produce
ROS production by a series of cellular events and
further leads to diabetic complications due to oxidative
stress [2,21]. Previously, a diabetes-induced increase in
ROS was indirectly demonstrated using lipid peroxida-
tion end-products (e.g., malondialdehyde [MDA]) as an
indicator [10,17].
In order to examine the dynamic process of diabetes-
stimulated ROS production and its correlation with
endothelial dysfunction, our study utilized hydroethi-
dine-sensitive vascular superoxide detection. One of the
most frequently used assays for the detection of cellular
O2
●- production utilizes hydroethidine as an intracellular
probe [22,23]. In the presence of O2
●-, hydroethidine is
rapidly converted to ethidium bromide, which binds to
DNA and is detected by its red fluorescent light follow-
ing minimal oxidation induced by H2O2, ONOO
-, or
HOCl- [24]. In situ nuclei labeled with ethidium bro-
mide along the arteriolar wall could be observed and the
Figure 3 Sodium nitroprusside-induced arteriolar vasodilation. Sodium nitroprusside-induced changes in mesenteric arteriolar diameter
from control (con), diabetes (DM) and curcumin-treated groups (con+cur300, DM+cur30, DM+cur300). Data are means ± SEM (n = 5 for each
group). NS, no significant difference compared to control arterioles.
Figure 4 Number of ethidium bromide-positive nuclei. Histogram showing the ethidium bromide-positive nuclei along the mesenteric
arterioles of rats that were untreated diabetics (DM), diabetics treated with low curcumin (DM+cur30), diabetics treated with high curcumin (DM
+cur300), controls (con) or controls treated with curcumin (con+cur300) rats. Data are expressed as mean ± SEM (n = 5 for each group). NS, no
significant difference compared to control arterioles; **P < 0.01 and *P < 0.05, significant difference compared to control arterioles; †† P < 0.01,
significant difference compared to diabetic arterioles.
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number of EB-sensitive nuclei could be quantitatively
estimated per 100 microns of vessel length, as shown in
Figure 4.
The results showed that superoxide production along
the arteriolar wall was about 4.45 times higher in DM
rats than controls. This excessive increase in vascular
superoxide may have destroyed the vascular endothelial
lining, yielding a 0.67-fold decrease in Ach response.
Interestingly, our findings have indicated that this
4.45-fold increase in superoxide production in diabetic
vasculature could be attenuated by daily oral curcumin
supplementation. However, there was no difference
between the low and high doses of curcumin in terms
of reducing superoxide production at the diabetic vascu-
lar wall. Both doses of curcumin examined in this study
were able to decrease superoxide production by almost
two-fold. Curcumin has been reported as a potent sca-
venger of a variety of ROS [25], exhibiting anti-
inflammatory activity as well as antioxidant properties
[17,26-29]. The phenolic (OH) structure of curcumin
was believed to be essential for curcumin’s anti-oxidant
activity [28].
In addition, the anti-oxidant effect of curcumin on
protecting endothelial function against ROS damage
may be partially attributed to the hypoglycemic effect of
curcumin. Our findings are consistent with others show-
ing that treatment with curcumin in diabetic rats leads
to lower plasma glucose levels [17,29]. However, the
new finding in the present study was that the hypoglyce-
mic potential of curcumin is dose dependent (Table 1).
Figure 5 Immunofluorescent staining for PKC-bII. PKC-bII and TRITC signals from immunofluorescent staining of mesenteric arteries.
Microvessels with diameter of approximately 100 μm were fixed in 4% paraformaldehyde for 24 hours and then embedded in paraffin. They
were later deparaffinized in xylene and rehydrated in a mixture of ethanol and distilled water. Antigens were unmasked using sodium citrate (10
mmol/L, pH 6.0), followed by exposure to a microwave heat source. Samples were then incubated at room temperature for 60 minutes with
anti-PKC-bII at 1:100. Sections were washed in PBS and incubated with swine anti-rabbit IgG-TRITC (1:50 in PBS) for 30 minutes at room
temperature. Immunofluorescent staining of small mesenteric arteries displayed a strong signal for PKC-bII in DM rats (Figure 5C). In contrast, the
TRITC signals of anti-PKC-bII antibodies were weak in the controls and DM+cur rat vessels (Figure 5 B and D, respectively). The negative control
displayed a minimal detectable fluorescence when the secondary antibodies were used alone (Figure 5A).
Rungseesantivanon et al. BMC Complementary and Alternative Medicine 2010, 10:57
http://www.biomedcentral.com/1472-6882/10/57
Page 6 of 9
Since HbA1c is the product of non-enzymatic glycosyla-
tion, therefore, it is mostly a better indicator of glycemic
control than plasma glucose level. Although the
mechanisms underlying the anti-diabetic action of cur-
cumin remain unknown, it has been suggested by other
investigators that curcumin may inhibit hepatic glucose
output and/or stimulate insulin secretion from the pan-
creas [26,30,31]. Moreover, it has been reported recently
that the anti-diabetic potential of anti-oxidants such as
vitamin C could protect glucose transporter 1 (GLUT-1)
[32]. Therefore, the hypoglycemic effect of curcumin
may be attributed to this effect on GLUT-1 as well.
STZ induces cytotoxicity mediated by reactive oxygen
species, as evidenced by B cell damage. Therefore, it is
possible that the hypoglycemic effect of curcumin,
mediated by stimulating insulin secretion from the pan-
creas, may be limited by the number of B cells remain-
ing. Therefore, the antidiabetic effect of curcumin
should be further clarified with the understanding that
curcumin supplementation cannot be used as an anti-
diabetic on its own.
The increase in hyperglycemia-induced oxygen-derived
free radicals was believed to be a major contributor to
the reduction of NO bioavailability observed in diabetes.
The interaction between NO and O2
●- occurs at an
extremely rapid rate, three times faster than the rate of
O2
●- reaction with SOD [33]. Therefore, this hyperglyce-
mia-induced O2
●- may quench NO, preventing endothe-
lium-dependent vasodilation [34-36].
Our findings showed that both low and high doses of
curcumin could significantly lower blood glucose by
18.73% and 30.26%, respectively, in the diabetic group.
In addition, the results also showed that both low and
high doses of curcumin could decrease diabetic vascular
superoxide production down by 55.1% and 57.1%,
respectively. Simultaneously, both doses of curcumin
were able to increase ACh-activated vasodilatation by up
to 30.22% and 46.47%, respectively. Although our study
did not monitor NO production directly, this parameter
can be measured indirectly by quantifying endothelial-
dependent vasodilation. Our findings in this regard indi-
cate that curcumin supplementation could enhance
endothelial-dependent relaxation in diabetic rats. John-
son et al. used in vitro studies to determine that the
mechanism of curcumin-mediated protection against
NO oxidation involves the sequestration of reaction
intermediates [35]. The IC50 for curcumin with 1.0 μM
DEA/NO was calculated to be 13 μM. Moreover, the
authors also suggested that the mechanism of curcumin
action involved the sequestration of NO2 but not NO.
Previous studies in rat aortic rings also demonstrated
that curcumin (10(-11) mol/L) could alleviate the acute
increase in glucose levels induced by dysfunctional
endothelium-dependent vasodilation [37]. The authors
suggested that the effect of curcumin may be due to its
ability to enhance heme oxygenase and guanylate cyclase
(GC) activity. Ach as well as NO-stimulated cGMP sig-
naling is required for normal endothelium-dependent
Figure 6 Relationship between ethidium bromide-positive nuclei and % changes in ACh-induced arteriolar vasodilation. Relationship
between EB-positive nuclei per 100 μm vessel length and percentage of ACh-induced change in arteriolar diameter for diabetes (DM), diabetes
treated with 30 and 300 mg/kg curcumin (DM+cur30 and DM+cur300, respectively), control (con) and control treated with 300 mg/kg curcumin
(con+cur300).
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vasodilation. Therefore, the protective effect of curcu-
min on vasodilatation could be completely eliminated by
the non-selective guanylate cyclase (GC) inhibitor
methylene blue [37].
A clinical study by Usharani et al. (2008) [38] showed
that NCB-02 (two capsules containing curcumin 150 mg
twice daily) significantly reduced the levels of malondial-
dehyde, ET-1, IL-6 and TNF[alpha] in type 2 diabetes
patients. Therefore, the molecular mechanisms of curcu-
min-mediated increases in vascular NO bioavailability
might be enhanced by its anti-oxidant properties and by
its anti-inflammatory effects. Notably, the pharmacoki-
netics of curcumin have recently been found to be asso-
ciated with many pathophysiologies via its actions on
signaling networks such as the NF-B and MAPK/ERK
pathways [39,40].
Numerous studies have shown that both free fatty acids
and high glucose levels in diabetes may activate PKC in
various vascular cells via de novo synthesis of diacylglycerol
(DAG) [41]. In addition, it has been reported that such
activated PKC could facilitate increased O2
●- production
through PKC-dependent activation of NAD(P)H oxidase
in vascular cells [42,43]. Activated PKC result in sustained
increases in the production of O2
●- and induce oxidative
damage to diabetic blood vessels, and it also induces a
number of pathogenic consequences by activating NF-B
and affecting the expression of endothelial nitric oxide
synthetase (eNOS), endothelin-1(ET-1), vascular endothe-
lial growth factor (VEGF), transforming growth factor-b
(TGF-b) and plasminogen activator inhibitor-1 (PAI-1)
[42,44]. Therefore, in the present study, the effect of high-
dose curcumin on activated PKC was further investigated.
Immunofluorescent micrographs revealed that diabetes-
activated PKC expression was increased markedly in 12-
week diabetic mesenteric arterial wall. Interestingly, the
immunofluorescent micrograph indicated that curcumin
supplementation, at a dose of 300 mg/kg, could suppress
this diabetes-activated PKC expression (Figure 5D). This
finding is in agreement with the previous report by Balasu-
bramanyam et al. (2003), which determined that the dose-
dependent ROS inhibitory effect of curcumin interfered
mechanistically with PKC activity [45].
In order to confirm the importance of curcumin
action, the correlation between HE-sensitive superoxide
production and ACh-induced arteriolar vasodilation was
examined for all five groups. These results were con-
firmed by the strong correlation between both para-
meters (0.78, P < 0.01).
Conclusion
In conclusion, diabetes-induced endothelial dysfunction
is closely associated with increases in oxidative stress
along the vascular wall. Curcumin supplementation can
improve diabetes-induced endothelial dysfunction
through its ability to decrease O2
●-production by inhi-
biting PKC. Curcumin supplementation may benefit dia-
betic patients by improving microvascular function and
preventing cardiovascular complications.
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